KPV peptide has emerged as a promising therapeutic candidate in recent years, drawing attention from researchers and clinicians alike for its unique anti-inflammatory properties and potential applications across a range of medical conditions. By harnessing the natural potency of this small tripeptide, scientists aim to develop targeted interventions that minimize side effects while maximizing efficacy.